MMP7 and hematopoietic and lymphoid system neoplasm: Despite its implications in AML, research specifically examining MMP7 in blood cancers remains remarkably limited, yet high levels of MMP7 have been associated with increased leukemic cell migration and resistance to apoptosis, suggesting its crucial role in disease progression and highlighting its potential as a therapeutic target [24–26].